Source comparison
Melanotan-2 Side Effects: Dosing Strategy Comparison
Different dosing strategies produce meaningfully different side effect profiles. The table below compares incidence rates and severity across three common protocols. | Dosing Strategy | Loading Phase | Nausea Incidence | Flushing Incidence | Cardiovascular Eff
This comparison does not assign a generated winner or score.
- Different dosing strategies produce meaningfully different side effect profiles. The table below compares incidence rates and severity across three common protocols.
- | Dosing Strategy | Loading Phase | Nausea Incidence | Flushing Incidence | Cardiovascular Effects | Hyperpigmentation Evenness | Professional Assessment ||—|—|—|—|—|—|| Aggressive (500 mcg daily) | 5–7 days | 60–75% | 50–65% | Tachycardia in 25–30%, transient BP changes common | Mottled, uneven darkening with disproportionate mole/freckle pigmentation | Highest side effect burden, fastest pigmentation, poorest cosmetic outcomes. Not recommended || Moderate (250 mcg daily) | 10–14 days | 40–55% | 35–50% | Tachycardia in 15–20%, occasional BP fluctuations | Moderate evenness, visible mole darkening, acceptable uniformity | Balanced approach. Manageable side effects with predictable timeline, most common research protocol || Conservative (100–150 mcg daily) | 14–21 days | 25–40% | 20–35% | Minimal cardiovascular effects (<10% incidence) | Best uniformity, gradual darkening, least mole contrast | Lowest side effect incidence, slowest results, best tolerated. Ideal for side effect-sensitiv
- The conservative protocol delays visible pigmentation by 7–10 days compared to aggressive dosing, but side effect severity drops by approximately 40–50% across all categories. The trade-off is duration: conservative users require 50–70% more total injections to reach equivalent pigmentation depth, extending the administration window from 2–3 weeks to 4–6 weeks.